Clicky

Ironwood Pharmaceuticals, Inc.(IRWD) News

Date Title
Feb 16 Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
Feb 16 Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
Feb 15 Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
Feb 15 Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Jan 9 Ironwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional Constipation
Jan 8 Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
Dec 5 Shareholders have faith in loss-making Ironwood Pharmaceuticals (NASDAQ:IRWD) as stock climbs 9.7% in past week, taking five-year gain to 2.3%
Nov 30 Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
Sep 12 Implied Volatility Surging for Ironwood (IRWD) Stock Options
Sep 7 Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report?
Aug 12 Is There An Opportunity With Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) 49% Undervaluation?
Aug 9 Ironwood's (IRWD) Reports Q2 Loss, Linzess Volume Rises
Aug 9 Q2 2023 Ironwood Pharmaceuticals Inc Earnings Call
Aug 8 Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates
Aug 8 Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance